{"id":"https://openalex.org/W1983553720","doi":"https://doi.org/10.1038/ajg.2009.528","title":"Prospective Analysis of Depression During Peginterferon and Ribavirin Therapy of Chronic Hepatitis C","display_name":"Prospective Analysis of Depression During Peginterferon and Ribavirin Therapy of Chronic Hepatitis C","publication_year":2009,"publication_date":"2009-09-29","ids":{"openalex":"https://openalex.org/W1983553720","doi":"https://doi.org/10.1038/ajg.2009.528","mag":"1983553720","pmid":"https://pubmed.ncbi.nlm.nih.gov/19789525"},"language":"en","primary_location":{"id":"doi:10.1038/ajg.2009.528","doi":"https://doi.org/10.1038/ajg.2009.528","is_oa":false,"landing_page_url":"https://doi.org/10.1038/ajg.2009.528","pdf_url":null,"source":{"id":"https://openalex.org/S66441642","display_name":"The American Journal of Gastroenterology","issn_l":"0002-9270","issn":["0002-9270","1572-0241"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"American Journal of Gastroenterology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5037987218","display_name":"Donna M. Evon","orcid":"https://orcid.org/0000-0002-1414-1846","observed_orcids":["https://orcid.org/0000-0002-1414-1846"]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Donna M. Evon","raw_affiliation_strings":["Division of Gastroenterology and Hepatology, University of North Carolina at Chapel Hill, North Carolina 27599, USA. donna_evon@med.unc.edu","Division of Gastroenterology and Hepatology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Gastroenterology and Hepatology, University of North Carolina at Chapel Hill, North Carolina 27599, USA. donna_evon@med.unc.edu","institution_ids":["https://openalex.org/I114027177"]},{"raw_affiliation_string":"Division of Gastroenterology and Hepatology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA","institution_ids":["https://openalex.org/I114027177"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079244174","display_name":"Darmendra Ramcharran","orcid":"https://orcid.org/0009-0009-2787-5265","observed_orcids":["https://orcid.org/0009-0009-2787-5265","https://orcid.org/0000-0001-7733-8649"]},"institutions":[{"id":"https://openalex.org/I170201317","display_name":"University of Pittsburgh","ror":"https://ror.org/01an3r305","country_code":"US","type":"education","lineage":["https://openalex.org/I170201317"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Darmendra Ramcharran","raw_affiliation_strings":["Epidemiology Data Center, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, Pennsylvania, USA","Via Research, LLC, Princeton Junction, New Jersey, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Epidemiology Data Center, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, Pennsylvania, USA","institution_ids":["https://openalex.org/I170201317"]},{"raw_affiliation_string":"Via Research, LLC, Princeton Junction, New Jersey, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108241779","display_name":"Steven H. Belle","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I170201317","display_name":"University of Pittsburgh","ror":"https://ror.org/01an3r305","country_code":"US","type":"education","lineage":["https://openalex.org/I170201317"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Steven H. Belle","raw_affiliation_strings":["Epidemiology Data Center, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, Pennsylvania, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Epidemiology Data Center, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, Pennsylvania, USA","institution_ids":["https://openalex.org/I170201317"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019470247","display_name":"Norah A. Terrault","orcid":"https://orcid.org/0000-0003-4143-1950","observed_orcids":["https://orcid.org/0000-0003-4143-1950"]},"institutions":[{"id":"https://openalex.org/I180670191","display_name":"University of California, San Francisco","ror":"https://ror.org/043mz5j54","country_code":"US","type":"education","lineage":["https://openalex.org/I180670191"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Norah A. Terrault","raw_affiliation_strings":["Division of Gastroenterology, University of California, San Francisco, San Francisco, California, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Gastroenterology, University of California, San Francisco, San Francisco, California, USA","institution_ids":["https://openalex.org/I180670191"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063597784","display_name":"Robert J. Fontana","orcid":"https://orcid.org/0000-0001-9161-5892","observed_orcids":["https://orcid.org/0000-0001-9161-5892"]},"institutions":[{"id":"https://openalex.org/I27837315","display_name":"University of Michigan","ror":"https://ror.org/00jmfr291","country_code":"US","type":"education","lineage":["https://openalex.org/I27837315"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Robert J. Fontana","raw_affiliation_strings":["Division of Gastroenterology, University of Michigan, Ann Arbor, Michigan, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Gastroenterology, University of Michigan, Ann Arbor, Michigan, USA","institution_ids":["https://openalex.org/I27837315"]}]},{"author_position":"last","author":{"id":null,"display_name":"Michael W. Fried","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michael W. Fried","raw_affiliation_strings":["Division of Gastroenterology and Hepatology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Gastroenterology and Hepatology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA","institution_ids":["https://openalex.org/I114027177"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5037987218"],"corresponding_institution_ids":["https://openalex.org/I114027177"],"apc_list":{"value":4390,"currency":"USD","value_usd":4390},"apc_paid":null,"fwci":6.1085,"has_fulltext":false,"cited_by_count":63,"citation_normalized_percentile":{"value":0.96671341,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"104","issue":"12","first_page":"2949","last_page":"295"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10151","display_name":"Hepatitis C virus research","score":0.9926999807357788,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10151","display_name":"Hepatitis C virus research","score":0.9926999807357788,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10272","display_name":"Mental Health Treatment and Access","score":0.001500000013038516,"subfield":{"id":"https://openalex.org/subfields/3207","display_name":"Social Psychology"},"field":{"id":"https://openalex.org/fields/32","display_name":"Psychology"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T11337","display_name":"Tryptophan and brain disorders","score":0.0010000000474974513,"subfield":{"id":"https://openalex.org/subfields/2803","display_name":"Biological Psychiatry"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/chronic-hepatitis-c","display_name":"chronic hepatitis C","score":0.8859999775886536},{"id":"https://openalex.org/keywords/depression","display_name":"depression","score":0.9879999756813049},{"id":"https://openalex.org/keywords/pegylated-interferon","display_name":"pegylated interferon","score":0.925000011920929},{"id":"https://openalex.org/keywords/ribavirin","display_name":"ribavirin","score":1.0},{"id":"https://openalex.org/keywords/combination-antiviral-therapy","display_name":"combination antiviral therapy","score":0.8930000066757202},{"id":"https://openalex.org/keywords/social-support","display_name":"social support","score":0.7860000133514404},{"id":"https://openalex.org/keywords/sustained-virologic-response","display_name":"sustained virological response","score":0.8349999785423279},{"id":"https://openalex.org/keywords/treatment-discontinuation","display_name":"treatment discontinuation","score":0.8730000257492065},{"id":"https://openalex.org/keywords/antidepressant-use","display_name":"antidepressant use","score":0.7160000205039978},{"id":"https://openalex.org/keywords/psychiatric-adverse-events","display_name":"psychiatric adverse events","score":0.972000002861023},{"id":"https://openalex.org/keywords/african-americans","display_name":"African Americans","score":0.5040000081062317},{"id":"https://openalex.org/keywords/racial-differences","display_name":"racial differences","score":0.609000027179718},{"id":"https://openalex.org/keywords/incidence-of-depression","display_name":"depression incidence","score":0.32600000500679016},{"id":"https://openalex.org/keywords/suicide-risk","display_name":"suicide risk","score":0.5410000085830688},{"id":"https://openalex.org/keywords/treatment-outcomes","display_name":"treatment outcomes","score":0.453000009059906},{"id":"https://openalex.org/keywords/patient-characteristics","display_name":"patient characteristics","score":0.49799999594688416}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9728847146034241},{"id":"https://openalex.org/C2780040827","wikidata":"https://www.wikidata.org/wiki/Q421862","display_name":"Ribavirin","level":4,"score":0.9578996300697327},{"id":"https://openalex.org/C2776867660","wikidata":"https://www.wikidata.org/wiki/Q1814941","display_name":"Depression (economics)","level":2,"score":0.6875678896903992},{"id":"https://openalex.org/C3020491458","wikidata":"https://www.wikidata.org/wiki/Q131742","display_name":"Chronic hepatitis","level":3,"score":0.6465833187103271},{"id":"https://openalex.org/C2776455275","wikidata":"https://www.wikidata.org/wiki/Q154869","display_name":"Hepatitis C","level":2,"score":0.5343114137649536},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.47874611616134644},{"id":"https://openalex.org/C188816634","wikidata":"https://www.wikidata.org/wiki/Q2113324","display_name":"Prospective cohort study","level":2,"score":0.4525611996650696},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.44335824251174927},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.33300548791885376},{"id":"https://openalex.org/C2522874641","wikidata":"https://www.wikidata.org/wiki/Q808","display_name":"Virus","level":2,"score":0.08539509773254395},{"id":"https://openalex.org/C139719470","wikidata":"https://www.wikidata.org/wiki/Q39680","display_name":"Macroeconomics","level":1,"score":0.0},{"id":"https://openalex.org/C162324750","wikidata":"https://www.wikidata.org/wiki/Q8134","display_name":"Economics","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D000077190","descriptor_name":"Interferon alpha-2","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000998","descriptor_name":"Antiviral Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D000998","descriptor_name":"Antiviral Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D003430","descriptor_name":"Cross-Sectional Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003863","descriptor_name":"Depression","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":true},{"descriptor_ui":"D003863","descriptor_name":"Depression","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D004359","descriptor_name":"Drug Therapy, Combination","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011446","descriptor_name":"Prospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011994","descriptor_name":"Recombinant Proteins","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012254","descriptor_name":"Ribavirin","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D012254","descriptor_name":"Ribavirin","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D014481","descriptor_name":"United States","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015337","descriptor_name":"Multicenter Studies as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015994","descriptor_name":"Incidence","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015995","descriptor_name":"Prevalence","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016009","descriptor_name":"Chi-Square Distribution","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016016","descriptor_name":"Proportional Hazards Models","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016032","descriptor_name":"Randomized Controlled Trials as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016898","descriptor_name":"Interferon-alpha","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D016898","descriptor_name":"Interferon-alpha","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D019698","descriptor_name":"Hepatitis C, Chronic","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1038/ajg.2009.528","doi":"https://doi.org/10.1038/ajg.2009.528","is_oa":false,"landing_page_url":"https://doi.org/10.1038/ajg.2009.528","pdf_url":null,"source":{"id":"https://openalex.org/S66441642","display_name":"The American Journal of Gastroenterology","issn_l":"0002-9270","issn":["0002-9270","1572-0241"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"American Journal of Gastroenterology","raw_type":"journal-article"},{"id":"pmid:19789525","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/19789525","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The American journal of gastroenterology","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G1129611741","display_name":"Hepatitis C: host determinants of progression and respo*","funder_award_id":"U01DK060341","funder_id":"https://openalex.org/F4320337357","funder_display_name":"National Institute of Diabetes and Digestive and Kidney Diseases"},{"id":"https://openalex.org/G1505263124","display_name":"Mentoring Junior Faculty:  Viral hepatitis Clinical Research","funder_award_id":"K24DK066144","funder_id":"https://openalex.org/F4320337357","funder_display_name":"National Institute of Diabetes and Digestive and Kidney Diseases"},{"id":"https://openalex.org/G1669594281","display_name":"Differential cytokine responses in Hep C patients.","funder_award_id":"U01DK060309","funder_id":"https://openalex.org/F4320337357","funder_display_name":"National Institute of Diabetes and Digestive and Kidney Diseases"},{"id":"https://openalex.org/G1784272205","display_name":"Interferon Resistance in Genotype 1 HCV","funder_award_id":"U01DK060349","funder_id":"https://openalex.org/F4320337357","funder_display_name":"National Institute of Diabetes and Digestive and Kidney Diseases"},{"id":"https://openalex.org/G2114018974","display_name":"Race &Viral Resistance in Chronic Hepatitis C (VIRAHEP*","funder_award_id":"U01DK060324","funder_id":"https://openalex.org/F4320337357","funder_display_name":"National Institute of Diabetes and Digestive and Kidney Diseases"},{"id":"https://openalex.org/G2623685141","display_name":"Response of HCV to Therapy in African Americans","funder_award_id":"U01DK060345","funder_id":"https://openalex.org/F4320337357","funder_display_name":"National Institute of Diabetes and Digestive and Kidney Diseases"},{"id":"https://openalex.org/G2721354581","display_name":null,"funder_award_id":"M02 RR 000079","funder_id":"https://openalex.org/F4320337375","funder_display_name":"National Center for Research Resources"},{"id":"https://openalex.org/G2920240559","display_name":"Hepatitis C Antiviral Resistance in African Americans","funder_award_id":"U01DK060327","funder_id":"https://openalex.org/F4320337357","funder_display_name":"National Institute of Diabetes and Digestive and Kidney Diseases"},{"id":"https://openalex.org/G3505631406","display_name":"General Clinical Research Center","funder_award_id":"M01RR016500","funder_id":"https://openalex.org/F4320337375","funder_display_name":"National Center for Research Resources"},{"id":"https://openalex.org/G3563617019","display_name":"Study of Viral Resistance to Antiviral Therapy of Chron*","funder_award_id":"U01DK060329","funder_id":"https://openalex.org/F4320337357","funder_display_name":"National Institute of Diabetes and Digestive and Kidney Diseases"},{"id":"https://openalex.org/G4008587197","display_name":"VIRAHEP-C Clinical Center","funder_award_id":"U01DK060344","funder_id":"https://openalex.org/F4320337357","funder_display_name":"National Institute of Diabetes and Digestive and Kidney Diseases"},{"id":"https://openalex.org/G4137263475","display_name":"General Clinical Research Center","funder_award_id":"M01RR000046","funder_id":"https://openalex.org/F4320337375","funder_display_name":"National Center for Research Resources"},{"id":"https://openalex.org/G5580083314","display_name":"HCV TREATMENT IN AFRICAN AMERICANS VS NON HISPANIC WHIT*","funder_award_id":"U01DK060352","funder_id":"https://openalex.org/F4320337357","funder_display_name":"National Institute of Diabetes and Digestive and Kidney Diseases"},{"id":"https://openalex.org/G6076478312","display_name":"Antiviral Therapy in African Americans with HCV","funder_award_id":"U01DK060340","funder_id":"https://openalex.org/F4320337357","funder_display_name":"National Institute of Diabetes and Digestive and Kidney Diseases"},{"id":"https://openalex.org/G652876763","display_name":"Baltimore VIRAHEP-C Clinical Center","funder_award_id":"U01DK060335","funder_id":"https://openalex.org/F4320337357","funder_display_name":"National Institute of Diabetes and Digestive and Kidney Diseases"},{"id":"https://openalex.org/G7823163308","display_name":"Cellular Immune Mechanisms of Resistance to HCV Therapy","funder_award_id":"U01DK060342","funder_id":"https://openalex.org/F4320337357","funder_display_name":"National Institute of Diabetes and Digestive and Kidney Diseases"},{"id":"https://openalex.org/G8297551062","display_name":"General Clinical Research Center","funder_award_id":"M01RR000042","funder_id":"https://openalex.org/F4320337375","funder_display_name":"National Center for Research Resources"},{"id":"https://openalex.org/G879746462","display_name":"Resistance to Antiviral Therapy in Chronic Hepatitis C","funder_award_id":"U01DK060346","funder_id":"https://openalex.org/F4320337357","funder_display_name":"National Institute of Diabetes and Digestive and Kidney Diseases"},{"id":"https://openalex.org/G8970635779","display_name":"GENERAL CLINICAL RESEARCH CENTER","funder_award_id":"M01RR000645","funder_id":"https://openalex.org/F4320337375","funder_display_name":"National Center for Research Resources"}],"funders":[{"id":"https://openalex.org/F4320337357","display_name":"National Institute of Diabetes and Digestive and Kidney Diseases","ror":"https://ror.org/00adh9b73"},{"id":"https://openalex.org/F4320337375","display_name":"National Center for Research Resources","ror":"https://ror.org/04pw6fb54"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":50,"referenced_works":["https://openalex.org/W1507734594","https://openalex.org/W1534046497","https://openalex.org/W1709632812","https://openalex.org/W1792389655","https://openalex.org/W1965813184","https://openalex.org/W1976458442","https://openalex.org/W1976752701","https://openalex.org/W1986730863","https://openalex.org/W1986891518","https://openalex.org/W1993630003","https://openalex.org/W1994799935","https://openalex.org/W1996850319","https://openalex.org/W1998976706","https://openalex.org/W2008981562","https://openalex.org/W2011809148","https://openalex.org/W2015033812","https://openalex.org/W2017701263","https://openalex.org/W2023092523","https://openalex.org/W2027545702","https://openalex.org/W2027953553","https://openalex.org/W2032889184","https://openalex.org/W2053748747","https://openalex.org/W2059365520","https://openalex.org/W2063891011","https://openalex.org/W2064826311","https://openalex.org/W2067855438","https://openalex.org/W2072160870","https://openalex.org/W2073335308","https://openalex.org/W2082240834","https://openalex.org/W2088732481","https://openalex.org/W2089417699","https://openalex.org/W2091341212","https://openalex.org/W2100019263","https://openalex.org/W2103111074","https://openalex.org/W2106173816","https://openalex.org/W2110356839","https://openalex.org/W2112778345","https://openalex.org/W2113957290","https://openalex.org/W2119526257","https://openalex.org/W2127685726","https://openalex.org/W2128762029","https://openalex.org/W2130844638","https://openalex.org/W2132147975","https://openalex.org/W2141559815","https://openalex.org/W2150164306","https://openalex.org/W2151947736","https://openalex.org/W2152211813","https://openalex.org/W2159847907","https://openalex.org/W2168911689","https://openalex.org/W2411026194"],"related_works":["https://openalex.org/W2328464843","https://openalex.org/W2133964873","https://openalex.org/W2599584631","https://openalex.org/W2410935855","https://openalex.org/W2154066696","https://openalex.org/W4231327786","https://openalex.org/W1925910633","https://openalex.org/W4244628229","https://openalex.org/W2067431237","https://openalex.org/W2023916252"],"abstract_inverted_index":{"OBJECTIVES:":[0],"Combination":[1],"therapy":[2],"for":[3,81],"chronic":[4],"hepatitis":[5],"C":[6,60],"is":[7],"associated":[8,154,243,336],"with":[9,130,155,244,297,337,361],"depression,":[10,157],"which":[11],"may":[12],"lead":[13],"to":[14,24,38,54,170,185,206,268],"worse":[15],"treatment":[16,36,45,104,189,264,285,341],"outcomes.":[17,46],"The":[18,213,354],"objectives":[19],"of":[20,57,76,98,208,215,224,284,294,312,356],"this":[21,323,327],"study":[22,62],"were":[23,63,88,128,153,167,200,226,265,306,335],"determine":[25],"the":[26,40,51,79,112,310],"association":[27],"between":[28,42,121,317,349],"patient":[29,123,151,338],"characteristics":[30,124,152,339],"and":[31,34,37,44,96,100,125,184,230,252,291,319,332,340,351],"depression":[32,43,127,217,240,262,300,316,334],"before":[33,90],"during":[35,263],"evaluate":[39],"relationship":[41,355],"METHODS:":[47],"Prospective":[48],"data":[49],"from":[50],"Viral":[52],"Resistance":[53],"Antiviral":[55],"Therapy":[56],"Chronic":[58],"Hepatitis":[59],"(Virahep-C)":[61],"analyzed":[64],"(191":[65],"African":[66],"Americans,":[67],"203":[68],"Caucasians).":[69],"Depression":[70,84],"was":[71,109,218,241],"defined":[72],"as":[73],"a":[74,270],"score":[75],">23":[77],"on":[78,228],"Center":[80],"Epidemiologic":[82],"Studies":[83],"(CES-D)":[85],"scale.":[86],"Scores":[87],"taken":[89],"treatment,":[91,99,164],"at":[92],"weeks":[93,102],"4,":[94],"12,":[95],"24":[97,101,221],"after":[103],"ended.":[105],"Baseline":[106],"social":[107,160,249,359],"support":[108,161,250,360],"measured":[110],"using":[111],"Medical":[113],"Outcomes":[114],"Study":[115],"(MOS)":[116],"Social":[117],"Support":[118],"Survey.":[119],"Associations":[120],"baseline":[122,156,211,331,358],"incident":[126],"assessed":[129],"discrete-time":[131],"Cox":[132],"proportional":[133],"hazards":[134],"models.":[135],"RESULTS:":[136],"At":[137],"baseline,":[138],"47":[139],"(12%)":[140],"participants":[141,209,321],"had":[142,187,281],"CES-D":[143],"scores":[144],"23.":[145],"Univariable":[146],"analyses":[147,236],"indicated":[148,237],"that":[149,238],"several":[150],"including":[158],"lower":[159,248,282,357],"(P<0.0001).":[162],"On":[163],"these":[165],"patients":[166,225,232,298],"more":[168,266],"likely":[169,267],"have":[171,186,269],"psychiatric":[172,271],"adverse":[173],"events":[174],"(AEs)":[175],"or":[176,256,273,314],"start":[177],"new":[178],"antidepressants":[179,275],"(45":[180],"vs.":[181,203,277,288,302],"28%,":[182],"P=0.02)":[183,290],"early":[188],"discontinuation":[190,286],"(38":[191,202],"vs.13%,":[192],"P<0.0001);":[193],"however,":[194,343],"sustained":[195],"virological":[196],"response":[197],"(SVR)":[198],"rates":[199,283,293,345],"similar":[201],"40%,":[204],"P=0.79)":[205],"those":[207],"without":[210,299],"depression.":[212],"incidence":[214],"new-onset":[216,239,315,333],"26%":[219],"by":[220],"weeks.":[222],"One-third":[223],"started":[227],"antidepressants,":[229],"no":[231,307],"attempted":[233],"suicide.":[234],"Multivariable":[235],"significantly":[242],"younger":[245],"age":[246],"(P=0.04),":[247],"(P<0.001),":[251],"\"feeling":[253],"depressed,":[254],"sad,":[255],"blue\"":[257],"(P=0.008).":[258],"Patients":[259],"who":[260],"developed":[261],"AE":[272],"begin":[274],"(44":[276],"23%,":[278],"P<0.001)":[279],"but":[280],"(6":[287],"15%,":[289],"comparable":[292],"SVR":[295,344],"compared":[296],"(47":[301],"38%,":[303],"P=0.16).":[304],"There":[305],"differences":[308],"in":[309,322],"frequency":[311],"pretreatment":[313],"African-American":[318],"Caucasian":[320],"study.":[324],"CONCLUSIONS:":[325],"In":[326],"large":[328],"prospective":[329],"analysis,":[330],"outcomes;":[342],"did":[346],"not":[347],"differ":[348],"depressed":[350],"nondepressed":[352],"patients.":[353],"depressive":[362],"symptoms":[363],"warrants":[364],"further":[365],"investigation.":[366]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":4},{"year":2015,"cited_by_count":7},{"year":2014,"cited_by_count":5},{"year":2013,"cited_by_count":11},{"year":2012,"cited_by_count":13}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}